Calabro’, Anna
Abdelhafez, Yasser G.
Triumbari, Elizabeth K. A.
Spencer, Benjamin A.
Chen, Moon S. Jr.
Albano, Domenico
Cassim, Christopher R.
Bertagna, Francesco
Dondi, Francesco
Cherry, Simon R.
Badawi, Ramsey D.
Sen, Fatma
Nardo, Lorenzo
Funding for this research was provided by:
Foundation for the National Institutes of Health (P30CA093373-18S4, R01CA249422)
Article History
Received: 26 June 2022
Accepted: 21 December 2022
First Online: 10 January 2023
Declarations
:
: The University of California, Davis Institutional Review Board approved the study protocols (#1341792, #1714742 and #1470016) and written informed consent was obtained from all participants. The study was performed in accordance with the declaration of Helsinki.
: Not applicable.
: UC Davis has a revenue-sharing agreement with United Imaging Healthcare. RDB, SRC, and LN and are investigators on a research grant funded by United Imaging Healthcare. No other potential conflicts of interest relevant to this article exist. LN is site Principal Investigator of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is site Principal Investigator of a clinical trial supported by Telix Pharmaceuticals. LN is site Principal Investigator a clinical trial supported by Lantheus Medical Imaging. LN is site Principal Investigator of a clinical trials supported by General Electric Healthcare.